Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

Citrate · Orfadin

Other · developed by Swedish Orphan Biovitrum

Approved FDA
1 Registered trials

What is Citrate?

Shohl's solution is a citrate buffer containing citric acid and sodium citrate. It is studied in iron-refractory iron-deficiency anemia.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Orfadin
Drug type
Other
Therapy area
Hematology
Developer
Swedish Orphan Biovitrum Ab
In trials of
RMTI
FDA status
Approved as Orfadin, NDA206356 · FDA label

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT02905981 Phase 2 Iron-Refractory Iron-Deficiency Anemia Terminated RMTI

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Iron-Refractory Iron-Deficiency Anemia

Sources

Updated Oct 3, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.